Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-28

Clinical Trial Update: Proof of Mechanism Study for the Treatment of Social Anhedonia in ASD [Phase 2]

View source ↗

Summary

Phase 2 proof-of-mechanism study investigating a treatment for social anhedonia in autism spectrum disorder (ASD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, Los Angeles | Conditions: ASD | Phase 2 | Status: UNKNOWN